Jefferies Group’s CureVac CVAC Stock Holding History

Jefferies Group’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-64,000	Closed	-$4.7M	–	1768
2021 Q2	$4.7M	Buy	+64,000	New	+$6.4M	0.03%	482

Other funds holding CVAC

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Jefferies Group's CVAC Position: Q3 2021 in Review

Jefferies Group sold out of CureVac (CVAC) in Q3 2021, closing a stake of 4,060 shares — an estimated $298K sold.

Jefferies Group first reported a position in CVAC in Q4 2020 and held it in 2 quarters. The position peaked at $350K in Q4 2020. 111 funds tracked by Wall St. Rank hold CVAC as of Q3 2021.

Jefferies Group reported no remaining CureVac position as of Q3 2021 after selling out during the quarter.
Jefferies Group sold 4,060 CureVac shares in Q3 2021, an estimated $298K.
Jefferies Group first reported a position in CureVac in Q4 2020 and held it in 2 quarters.
Jefferies Group's CureVac position peaked at $350K in Q4 2020.
111 funds tracked by Wall St. Rank held CureVac as of Q3 2021.

Based on Jefferies Group's 13F filing for Q3 2021, filed 15 Nov 2021.